| --- | --- | |----------------------|-------| | | | | | | | Unlocking the | | | potential of today's | | | | | | medicines for | | | profound impact | | March 2021 Xeris Pharmaceuticals, Inc. ©2017-2020 All Rights Reserved Forward-looking Statements 2 This presentation may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the rate and degree of market acceptance and clinical utility of Gvoke®, the market and the the ...